NL7206941A - - Google Patents

Info

Publication number
NL7206941A
NL7206941A NL7206941A NL7206941A NL7206941A NL 7206941 A NL7206941 A NL 7206941A NL 7206941 A NL7206941 A NL 7206941A NL 7206941 A NL7206941 A NL 7206941A NL 7206941 A NL7206941 A NL 7206941A
Authority
NL
Netherlands
Application number
NL7206941A
Other versions
NL175988C (nl
NL175988B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NLAANVRAGE7206941,A priority Critical patent/NL175988C/xx
Priority to ZA733211A priority patent/ZA733211B/xx
Priority to US00359923A priority patent/US3850904A/en
Priority to GB2298473A priority patent/GB1435384A/en
Priority to AU55750/73A priority patent/AU470908B2/en
Priority to CH719673A priority patent/CH587229A5/xx
Priority to CA171,907A priority patent/CA1030954A/en
Priority to DE2326033A priority patent/DE2326033C2/de
Priority to HUAO365A priority patent/HU169159B/hu
Priority to JP48057638A priority patent/JPS5747667B2/ja
Priority to SE7307227A priority patent/SE407215B/sv
Priority to BE131443A priority patent/BE799939A/xx
Priority to FR7318960A priority patent/FR2185412B1/fr
Publication of NL7206941A publication Critical patent/NL7206941A/xx
Publication of NL175988B publication Critical patent/NL175988B/xx
Application granted granted Critical
Publication of NL175988C publication Critical patent/NL175988C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7206941,A 1972-05-24 1972-05-24 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden. NL175988C (nl)

Priority Applications (13)

Application Number Priority Date Filing Date Title
NLAANVRAGE7206941,A NL175988C (nl) 1972-05-24 1972-05-24 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
ZA733211A ZA733211B (en) 1972-05-24 1973-05-11 Psychopharmacologically active peptides
US00359923A US3850904A (en) 1972-05-24 1973-05-14 Psychopharmacologically active d-glu or d-his containing peptides
GB2298473A GB1435384A (en) 1972-05-24 1973-05-15 Psychopharmacologically active peptides
AU55750/73A AU470908B2 (en) 1972-05-24 1973-05-16 Psychopharmacologically active peptides
CH719673A CH587229A5 (fi) 1972-05-24 1973-05-21
CA171,907A CA1030954A (en) 1972-05-24 1973-05-22 Psychopharmacologically active peptides
DE2326033A DE2326033C2 (de) 1972-05-24 1973-05-22 Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel mit psychopharmakologischer Wirkung
HUAO365A HU169159B (fi) 1972-05-24 1973-05-23
JP48057638A JPS5747667B2 (fi) 1972-05-24 1973-05-23
SE7307227A SE407215B (sv) 1972-05-24 1973-05-23 Forfarande for framstellning av peptider med psykofarmakologiska egenskaper
BE131443A BE799939A (fr) 1972-05-24 1973-05-23 Peptides a activite psychopharmacologique
FR7318960A FR2185412B1 (fi) 1972-05-24 1973-05-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7206941,A NL175988C (nl) 1972-05-24 1972-05-24 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.

Publications (3)

Publication Number Publication Date
NL7206941A true NL7206941A (fi) 1973-11-27
NL175988B NL175988B (nl) 1984-09-03
NL175988C NL175988C (nl) 1985-02-01

Family

ID=19816103

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7206941,A NL175988C (nl) 1972-05-24 1972-05-24 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.

Country Status (13)

Country Link
US (1) US3850904A (fi)
JP (1) JPS5747667B2 (fi)
AU (1) AU470908B2 (fi)
BE (1) BE799939A (fi)
CA (1) CA1030954A (fi)
CH (1) CH587229A5 (fi)
DE (1) DE2326033C2 (fi)
FR (1) FR2185412B1 (fi)
GB (1) GB1435384A (fi)
HU (1) HU169159B (fi)
NL (1) NL175988C (fi)
SE (1) SE407215B (fi)
ZA (1) ZA733211B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438029A (en) 1978-01-19 1984-03-20 Research Corporation Synthetic peptides
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
NL8101724A (nl) * 1981-04-08 1982-11-01 Akzo Nv Peptiden met zenuw-regenererende eigenschappen.
US4500713A (en) * 1982-09-23 1985-02-19 Usv Pharmaceutical Corporation Therapeutic dipeptides
JPS62501147A (ja) * 1984-12-14 1987-05-07 オーストラリアン　コマーシャル　リサーチ　アンド　ディベロップメント　リミティド ヒト白血球エラスタ−ゼのアミノ酸阻害剤及びペプチド阻害剤
ES2710617T3 (es) 2010-04-21 2019-04-26 Signature Therapeutics Inc Composiciones que comprenden profármacos de anfetamina escindibles enzimáticamente e inhibidores de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL6509727A (fi) * 1965-07-28 1967-01-30
GB1301738A (fi) * 1969-07-09 1973-01-04

Also Published As

Publication number Publication date
JPS4948666A (fi) 1974-05-11
BE799939A (fr) 1973-11-23
JPS5747667B2 (fi) 1982-10-12
NL175988C (nl) 1985-02-01
FR2185412A1 (fi) 1974-01-04
CA1030954A (en) 1978-05-09
DE2326033A1 (de) 1973-12-20
DE2326033C2 (de) 1983-10-27
GB1435384A (en) 1976-05-12
AU5575073A (en) 1974-11-21
HU169159B (fi) 1976-10-28
US3850904A (en) 1974-11-26
NL175988B (nl) 1984-09-03
CH587229A5 (fi) 1977-04-29
SE407215B (sv) 1979-03-19
FR2185412B1 (fi) 1976-12-03
AU470908B2 (en) 1976-04-01
ZA733211B (en) 1974-04-24

Similar Documents

Publication Publication Date Title
FR2185412B1 (fi)
JPS5739242B2 (fi)
JPS5330338B2 (fi)
JPS4833441A (fi)
JPS5134388Y2 (fi)
JPS4957446U (fi)
JPS5216651Y2 (fi)
JPS5042875Y2 (fi)
JPS5331633B2 (fi)
JPS518865B2 (fi)
JPS4962727A (fi)
JPS497147U (fi)
JPS4962728U (fi)
JPS4987528A (fi)
CH590917A5 (fi)
BG18781A1 (fi)
BG17144A1 (fi)
CH561486A5 (fi)
CH566566A5 (fi)
CH590895A5 (fi)
CH590818A5 (fi)
CH589424A5 (fi)
CH587518A5 (fi)
CH587326A5 (fi)
CH587276A5 (fi)

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee